Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121826) titled 'Development and validation of Chemotherapy-Related Cognitive Impairment Intervention for patients with Breast Cancer' on April 3.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: West China Hospital, Sichuan University
Condition:
Breast Cancer
Intervention:
Intervention group:CRCI intervention scheme constructed in this study.
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-13
Target Sample Size: Intervention group:29;Control group:29;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=292704
P...